CDER releases policy for handling newly identified safety signals
The FDA’s Center for Drug Evaluation and Research (CDER) last week issued a new manual of policies and procedures (MAPP) explaining its internal process for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
